SG Americas Securities’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164K | Buy |
9,031
+419
| +5% | +$7.61K | ﹤0.01% | 2124 |
|
|
2025
Q1 | $171K | Buy |
8,612
+2,058
| +31% | +$40.9K | ﹤0.01% | 2356 |
|
|
2024
Q4 | $112K | Sell |
6,554
-37,638
| -85% | -$643K | ﹤0.01% | 2362 |
|
|
2024
Q3 | $883K | Sell |
44,192
-319,550
| -88% | -$6.38M | ﹤0.01% | 1031 |
|
|
2024
Q2 | $4.07M | Buy |
363,742
+352,320
| +3,085% | +$3.94M | 0.02% | 596 |
|
|
2024
Q1 | $75K | Sell |
11,422
-81,814
| -88% | -$537K | ﹤0.01% | 2328 |
|
|
2023
Q4 | $421K | Buy |
93,236
+75,213
| +417% | +$340K | ﹤0.01% | 1429 |
|
|
2023
Q3 | $65K | Buy |
+18,023
| New | +$65K | ﹤0.01% | 2600 |
|
|
2023
Q2 | – | Sell |
-58,507
| Closed | -$194K | – | 1909 |
|
|
2023
Q1 | $194K | Buy |
58,507
+29,327
| +101% | +$97.2K | ﹤0.01% | 2217 |
|
|
2022
Q4 | $113K | Sell |
29,180
-113,291
| -80% | -$439K | ﹤0.01% | 2397 |
|
|
2022
Q3 | $346K | Buy |
142,471
+96,048
| +207% | +$233K | ﹤0.01% | 1665 |
|
|
2022
Q2 | $92K | Buy |
+46,423
| New | +$92K | ﹤0.01% | 2868 |
|
|
2021
Q2 | – | Sell |
-18,968
| Closed | -$33K | – | 2476 |
|
|
2021
Q1 | $33K | Sell |
18,968
-4,242
| -18% | -$7.38K | ﹤0.01% | 2870 |
|
|
2020
Q4 | $45K | Buy |
+23,210
| New | +$45K | ﹤0.01% | 2746 |
|
|
2020
Q3 | – | Sell |
-118,200
| Closed | -$346K | – | 2133 |
|
|
2020
Q2 | $346K | Sell |
118,200
-7,560
| -6% | -$22.1K | ﹤0.01% | 2070 |
|
|
2020
Q1 | $362K | Buy |
+125,760
| New | +$362K | ﹤0.01% | 1729 |
|